Currently, there are 504.89M common shares owned by the public and among those 458.19M shares have been available to trade.
The company’s stock has a 5-day price change of -12.71% and -24.32% over the past three months. CLF shares are trading -34.77% year to date (YTD), with the 12-month market performance down to -20.05% lower. It has a 12-month low price of $13.80 and touched a high of $22.97 over the same period. CLF has an average intraday trading volume of 8.92 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -13.34%, -14.57%, and -26.33% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Cleveland-Cliffs Inc (NYSE: CLF) shares accounts for 72.61% of the company’s 504.89M shares outstanding.
It has a market capitalization of $6.23B and a beta (3y monthly) value of 1.99. The stock’s trailing 12-month PE ratio is 167.13, while the earnings-per-share (ttm) stands at $0.08. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.29% over the week and 3.60% over the month.
Earnings per share for the fiscal year are expected to decrease by -94.84%, and 1482.62% over the next financial year.
Looking at the support for the CLF, a number of firms have released research notes about the stock. JP Morgan stated their Neutral rating for the stock in a research note on June 11, 2024, with the firm’s price target at $23-$17. Jefferies coverage for the Cleveland-Cliffs Inc (CLF) stock in a research note released on May 20, 2024 offered a Buy rating with a price target of $22. Wolfe Research was of a view on April 09, 2024 that the stock is Underperform, while Citigroup gave the stock Neutral rating on March 13, 2024, issuing a price target of $22. Exane BNP Paribas on their part issued Underperform rating on February 28, 2024.
